• Memory loss? Confusion?

    Difficulty completing familiar tasks?


Consider the Epoch clinical research study

Alzheimer’s disease disrupts connections in the brain, causing memories and functions to fade. At first the only symptom may be short-term memory loss, which some people dismiss as a normal part of aging. But Alzheimer’s disease is far more than that. As the disease advances, one gradually loses long-term memory and the ability to do things independently.

Currently available are prescription medications that may help manage symptoms but do not slow the course of Alzheimer’s disease. Through ongoing clinical research, doctors evaluate study drugs that may control symptoms and, may possibly, help with disease management.

We are evaluating the effectiveness and safety of an oral study drug that may help slow the progression of mild to moderate Alzheimer’s disease.

To be considered for participation in the Epoch study, you must:

  • Be 55 to 85 years old
  • Have an Alzheimer’s disease diagnosis or think you may have Alzheimer’s disease
  • Have symptoms of mental or functional decline dating back at least 1 year
  • Agree to have a Magnetic Resonance Imaging (MRI) scan to confirm your diagnosis
  • Have a partner or caregiver willing to bring you to study visits and help you follow study requirements

Other eligibility requirements apply.

All study-related drugs and care will be provided at no cost. Participation is expected to last up to 20 months, including screening, study drug dosing and follow-up.

For More Information

To see if you may qualify for study participation, please click here.